12:00 AM
 | 
Jan 03, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Androxal enclomiphene regulatory update

Repros submitted data from 3 studies to FDA that demonstrate that the assessment of testosterone levels between 8-10 a.m. is indicative of maximum and average testosterone achieved during the day following the administration of Androxal enclomiphene....

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >